Discover 884 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 884
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Port Orange FL, Winter Park FL, Orlando FL, Ocala FL,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGANĀ® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
for
Glaucoma, Open-Angle, Ocular Hypertension
Location: New Smyrna Beach FL, Morrow GA, Roswell GA,
Sponsor: Amneal Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT05401357
Phase 3, Recruiting
Active & Responsive
DermaSensor Postmarket Surveillance Study
for
Melanoma, Skin
Location: New Smyrna Beach FL, Morehead City NC
Sponsor: DermaSensor, Inc.
Sex: All
Age: 40+
Code: NCT06666790
Recruiting
Active & Responsive
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
for
HIV-1-infection
Location: DeLand FL, Orlanda FL, Ft. Pierce FL, Sarasota FL,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07645287
Phase 2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: DeLand FL, Winter Park FL, Orlando FL, Viera FL,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: DeLand FL, Orlando FL, Winter Park FL, Jacksonville FL,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
for
Diabetic Peripheral Neuropathic Pain
Location: DeLand FL, Maitland FL, Winter Park FL, Lady Lake FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07285018
Phase 2, Recruiting
Active & Responsive
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
for
Osteoarthritis, Knee, Diabetic Neuropathic Pain,
Location: DeLand FL, Maitland FL, Winter Park FL, Lady Lake FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05986292
Phase 2, Recruiting
Active & Responsive
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
for
Cannabis Withdrawal
Location: DeLand FL, Tampa FL, Largo FL, West Palm Beach FL,
Sponsor: PleoPharma, Inc.
Sex: All
Age: 18 - 55
Code: NCT07644052
Phase 3, Recruiting
Active & Responsive
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
for
Epilepsy, Healthy Volunteer
Location: DeLand FL, Tamarac FL, Weston FL, Charlotte NC,
Sponsor: Suninflam Inc
Sex: All
Age: 18 - 70
Code: NCT07051629
Phase 1, Recruiting
Active & Responsive
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
for
Smoking Cessation
Location: DeLand FL, Orlando FL, Jacksonville FL, Tampa FL,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07766655
Phase 3, Recruiting
Active & Responsive
Prospective US Radiofrequency SUI Trial
for
Urinary Incontinence, Stress
Location: Orange City FL, Lake City FL, Tampa FL, Myrtle Beach SC,
Sponsor: Viveve Inc.
Sex: Female
Age: 18+
Code: NCT04720352
Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: DeLand FL, Orlando FL, Jacksonville FL, Vero Beach FL,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase 3, Recruiting
Active & Responsive
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Orange City FL, Maitland FL, Orlando FL, Tampa FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07412756
Phase 3, Recruiting
Active & Responsive
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Orange City FL, Altamonte Springs FL, Leesburg FL,
Sponsor: Expedition Therapeutics, Inc
Sex: All
Age: 40 - 70+
Code: NCT07684820
Phase 2, Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Orange City FL, Rockledge FL, Jacksonville FL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Active & Responsive
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
for
Advanced Non-squamous Non-small-cell Lung Cancer,
Location: Orange City FL, Clermont FL, Coral Springs FL,
Sponsor: Genelux Corporation
Sex: All
Age: 18+
Code: NCT06463665
Phase 2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Orange City FL, Clermont FL, Jacksonville FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase 3, Recruiting
Active & Responsive
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease